Invesco Global Listed Private Equity ETF (PSP)
| Assets | $263.73M |
| Expense Ratio | 1.80% |
| PE Ratio | 14.29 |
| Shares Out | 4.19M |
| Dividend (ttm) | $3.87 |
| Dividend Yield | 6.37% |
| Ex-Dividend Date | Mar 23, 2026 |
| Payout Frequency | Quarterly |
| Payout Ratio | 91.11% |
| Volume | 24,485 |
| Open | 60.85 |
| Previous Close | 60.74 |
| Day's Range | 60.42 - 61.03 |
| 52-Week Low | 54.18 |
| 52-Week High | 72.97 |
| Beta | 1.30 |
| Holdings | 70 |
| Inception Date | Oct 24, 2006 |
About PSP
Fund Home PageThe Invesco Global Listed Private Equity ETF (PSP) is an exchange-traded fund that mostly invests in financials equity. The fund tracks a modified market-cap weighted index of publicly listed private equity firms. PSP was launched on Oct 24, 2006 and is issued by Invesco.
Top 10 Holdings
45.81% of assets| Name | Symbol | Weight |
|---|---|---|
| Blackstone Inc. | BX | 5.22% |
| KKR & Co. Inc. | KKR | 5.15% |
| Partners Group Holding AG | PGHN | 5.11% |
| EQT AB (publ) | EQT | 5.04% |
| TPG Inc. | TPG | 4.70% |
| CVC Capital Partners plc | CVC | 4.50% |
| 3i Group plc | III | 4.34% |
| HAL Trust | HAL | 4.05% |
| Blue Owl Capital Inc. | OWL | 3.98% |
| Sofina Société Anonyme | SOF | 3.73% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Mar 23, 2026 | $0.15286 | Mar 27, 2026 |
| Dec 22, 2025 | $1.47174 | Dec 26, 2025 |
| Sep 22, 2025 | $0.83642 | Sep 26, 2025 |
| Jun 23, 2025 | $1.4049 | Jun 27, 2025 |
| Mar 24, 2025 | $0.22234 | Mar 28, 2025 |
| Dec 23, 2024 | $1.18802 | Dec 27, 2024 |
Performance
PSP had a total return of 4.11% in the past year, including dividends. Since the fund's inception, the average annual return has been 2.50%.
News
Collect 12% Yields By Investing Like A Billionaire In 2025
If you've been investing for a while, you've probably thought about private equity more than once. Adding exposure to “PE” firms, which buy and sell privately held businesses, is a great way to divers...
FDA Clears Abionic's IVD CAPSULE PSP for the Early Detection of Sepsis
EPALINGES, Switzerland--(BUSINESS WIRE)--Abionic, an emerging medical diagnostics company focused on rapid early detection technologies, announced today that its IVD CAPSULE PSP test has received 510(...